Discontinuation report OMNIPAQUE 180
| Report ID | 182757 |
| Drug Identification Number | 02172720 |
| Brand name | OMNIPAQUE 180 |
| Common or Proper name | iohexol injection USP |
| Company Name | GE HEALTHCARE CANADA INC |
| Market Status | MARKETED |
| Active Ingredient(s) | IOHEXOL |
| Strength(s) | 388MG |
| Dosage form(s) | SOLUTION |
| Route of administration | SUBARACHNOIDAL SUBARACHNOIDAL |
| Packaging size | 20 mL |
| ATC code | V08AB |
| ATC description | X-RAY CONTRAST MEDIA, IODINATED |
| Reason for discontinuation | Business reasons |
| Anticipated discontinuation date | 2023-06-02 |
| Actual discontinuation date | 2023-02-21 |
| Remaining supply date | 2023-06-02 |
| Discontinuation status | Discontinued |
| Discontinuation decision reversal | No |
| Information on remaining supply | |
| Company comments | |
| Health Canada comments | |
| Tier 3 Status | No |
| Contact Address | 1919 MINNESOTA COURT MISSISSAUGA, ONTARIO CANADA L5N 0C9 |
| Company contact information | 800-387-7146 canadainfo@ge.com |
Version History
Click on "Compare" below to view the full report history and compare to other versions.
| Version Number | Date Updated | Language | |
|---|---|---|---|
| v6 | 2023-02-22 | French | Compare |
| v5 | 2023-02-22 | French | Compare |
| v4 | 2023-02-22 | French | Compare |
| v3 | 2023-02-22 | English | Compare |
| v2 | 2023-01-31 | French | Compare |
| v1 | 2023-01-31 | English | Compare |
Showing 1 to 6 of 6